GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (STU:TQ80) » Definitions » Common Stock

Theratechnologies (STU:TQ80) Common Stock : €342.82 Mil (As of Nov. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Theratechnologies Common Stock?

Theratechnologies's quarterly common stock declined from May. 2024 (€336.63 Mil) to Aug. 2024 (€330.08 Mil) but then increased from Aug. 2024 (€330.08 Mil) to Nov. 2024 (€342.82 Mil).

Theratechnologies's annual common stock increased from Nov. 2022 (€332.32 Mil) to Nov. 2023 (€336.27 Mil) and increased from Nov. 2023 (€336.27 Mil) to Nov. 2024 (€342.82 Mil).


Theratechnologies Common Stock Historical Data

The historical data trend for Theratechnologies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Common Stock Chart

Theratechnologies Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 243.07 294.12 332.32 336.27 342.82

Theratechnologies Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 336.27 337.36 336.63 330.08 342.82

Theratechnologies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Theratechnologies Business Description

Traded in Other Exchanges
Address
2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Theratechnologies Headlines

No Headlines